Release Date: 20/09/16 12:38 Summary: Valentia Investment Update-EVM.AX Price Sensitive: No Download Document 816.21KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%